Polatuzumab vedotin
Definition: Polatuzumab vedotin, sold under the brand name Polivy, is an antibody-drug conjugate medication used for the treatment of diffuse large B-cell lymphoma (cancer). Polatuzumab is an antibody that targets CD79b, and vedotin is an agent that inhibits cell division by blocking the polymerisation of tubulin. It was developed by the Genentech subsidiary of Roche. source: Wikipedia
- ID
- 788328006
- ID date
- 7 Jan 2022
- Previous ID
- 38068011000001106
- Name
- Polatuzumab vedotin